BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25686745)

  • 1. MicroRNA-370 Attenuates Hepatic Fibrogenesis by Targeting Smoothened.
    Lu CH; Hou QR; Deng LF; Fei C; Xu WP; Zhang Q; Wu KM; Ning BF; Xie WF; Zhang X
    Dig Dis Sci; 2015 Jul; 60(7):2038-48. PubMed ID: 25686745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
    Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y
    Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
    Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-195 Activates Hepatic Stellate Cells In Vitro by Targeting Smad7.
    Song LY; Ma YT; Wu CF; Wang CJ; Fang WJ; Liu SK
    Biomed Res Int; 2017; 2017():1945631. PubMed ID: 28929107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
    Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
    Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
    Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
    Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Xie X; Dou CY; Zhou Y; Zhou Q; Tang HB
    Dig Dis Sci; 2021 Jun; 66(6):1928-1939. PubMed ID: 32648079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
    Sun J; Zhang H; Li L; Yu L; Fu L
    Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of liver cirrhosis achieved by inhibitory effect of miR-454 on hepatic stellate cells activation and proliferation via Wnt10a.
    Wang YZ; Zhang W; Wang YH; Fu XL; Xue CQ
    J Biochem; 2019 Apr; 165(4):361-367. PubMed ID: 30535384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-200a controls hepatic stellate cell activation and fibrosis via SIRT1/Notch1 signal pathway.
    Yang JJ; Tao H; Liu LP; Hu W; Deng ZY; Li J
    Inflamm Res; 2017 Apr; 66(4):341-352. PubMed ID: 28025657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway.
    Wang J; Chu ES; Chen HY; Man K; Go MY; Huang XR; Lan HY; Sung JJ; Yu J
    Oncotarget; 2015 Mar; 6(9):7325-38. PubMed ID: 25356754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
    Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types.
    Wang X; Seo W; Park SH; Fu Y; Hwang S; Rodrigues RM; Feng D; Gao B; He Y
    Int J Biol Sci; 2021; 17(4):1153-1167. PubMed ID: 33867837
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA-17-5p-activated Wnt/β-catenin pathway contributes to the progression of liver fibrosis.
    Yu F; Lu Z; Huang K; Wang X; Xu Z; Chen B; Dong P; Zheng J
    Oncotarget; 2016 Jan; 7(1):81-93. PubMed ID: 26637809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
    Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
    Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-145 inhibits hepatic stellate cell activation and proliferation by targeting ZEB2 through Wnt/β-catenin pathway.
    Zhou DD; Wang X; Wang Y; Xiang XJ; Liang ZC; Zhou Y; Xu A; Bi CH; Zhang L
    Mol Immunol; 2016 Jul; 75():151-60. PubMed ID: 27289031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gα
    Kim KM; Han CY; Kim JY; Cho SS; Kim YS; Koo JH; Lee JM; Lim SC; Kang KW; Kim JS; Hwang SJ; Ki SH; Kim SG
    J Hepatol; 2018 Mar; 68(3):493-504. PubMed ID: 29080810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.